40
NewcelX Ltd. raises $2.9M under Reg D
Company raise · Closed · Offering $2.9M · Sold $2.9M · Kloten, Switzerland · filed 2026-08-24
35
NLS Pharmaceutics Ltd. raises $1M under Reg D
Company raise · Closed · Zurich, Switzerland · Form D filed 2025-07-10
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Gian-Marco Rinaldi de la Cruz | Director |
| Olivier Samuel | Director |
| Alexander Zwyer | Chief Executive Officer |
| Nicole Fernandez-McGovern | Chief Financial Officer |
| Florence Allouche Aknin | Director |
| Ronald Hafner | Chairman of the Board of Directors |
Signed by Alexander Zwyer, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
NewcelX Ltd. raises $3.4M under Reg D
Company raise · Closed · Offering $3.4M · Sold $3.4M · Kloten, Switzerland · filed 2026-05-13
40
NLS Pharmaceutics Ltd. raises $2M under Reg D
Company raise · Closed · Offering $2M · Sold $2M · Zurich, Switzerland · filed 2025-04-14
25
NLS Pharmaceutics Ltd. raises $500K under Reg D
Company raise · Closed · Offering $500K · Sold $500K · Zurich, Switzerland · filed 2025-01-22
45
NLS Pharmaceutics Ltd. raises $7.2M under Reg D
Company raise · Closed · Offering $7.2M · Sold $7.2M · Zurich, Switzerland · filed 2024-10-21